GI CANCER CHRONICLES Trademark

Trademark Overview


On Thursday, March 14, 2024, a trademark application was filed for GI CANCER CHRONICLES with the United States Patent and Trademark Office. The USPTO has given the GI CANCER CHRONICLES trademark a serial number of 98449528. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 3, 2024. This trademark is owned by Astellas Pharma Inc.. The GI CANCER CHRONICLES trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information
gi cancer chronicles

General Information


Serial Number98449528
Word MarkGI CANCER CHRONICLES
Filing DateThursday, March 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkGASTROINESTINAL CANCER CHRONICLES
Goods and ServicesProviding medical information

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code044
First Use Anywhere DateMonday, March 4, 2024
First Use In Commerce DateMonday, March 4, 2024

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events


Event DateEvent Description
Thursday, March 14, 2024NEW APPLICATION ENTERED
Wednesday, August 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 30, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NON-FINAL ACTION WRITTEN